TIAFT joint session with IATDMCT. Martinique, June 6, 2008

AACC-IATDMCT Joint Symposium LC/MS and LC MS/MS in Clinical and Forensic Toxicology, Jul 26, 2008 Registration form

International Conference Therapeutic drug monitoring in optimizing immunosuppressive therapy. Warsaw, Poland, September 26-27, 2008

To promote the knowledge and understanding of clinical drug analysis and interpretation of results.

To enhance communication between scientists and physicians of all disciplines involved in therapeutic drug monitoring and clinical toxicology.

To encourage the effective application of therapeutic drug monitoring and clinical toxicology; with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.

Application form (PDF) (Word)

IATDMCT is assuming ownership of Therapeutic Drug Monitoring journal

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Current

2007-2009 IATDMCT Council
(larger picture)

President
Prof. H. H. Maurer, Homburg/Saar, Germany
(hans.maurer@uniklinikum-saarland.de)

Past-President
Prof. D.W. Holt, London, United Kingdom
(dwhasil@aol.com)

President-Elect
Prof. A.A. Vinks, Cincinnati OH, USA
(sander.vinks@chmcc.org)

Secretary
Prof. P. Marquet, Limoges, France
(pierre.marquet@unilim.fr )

Treasurer
Prof. V. Armstrong, Göttingen, Germany
(varmstro@med.uni-goettingen.de)

Directors of Education
Dr. M. Huestis, Baltimore, MD, USA (mhuestis@intra.nida.nih.gov )
Prof. A. Johnston, London, UK
(A.Johnston@qmul.ac.uk )
Prof. S. Solari, Santiago, Chile
(ssolari@med.puc.cl )

Councillors
Dr. C. Collier, Kingston ON, Canada
(collier@cliff.path.queensu.ca)
Dr. L. Langman, Rochester, MN, USA
(Langman.Loralie@mayo.edu )
Dr. T. Van Gelder, Rotterdam, The Netherlands (t.vangelder@erasmusmc.nl )
Prof. P. Wallemacq, Brussels, Belgium
(wallemacq@lbcm.ucl.ac.be )

Administrative director:
Mrs. Elizabeth Hooper, (office@iatdmct.org)

Members Only

Events

Login

Our aims are:

Journal

Current